Loading insider details...
Beta
Latest Form 4 (Feb 4, 2026): Grant/Award of 170,000 FULC shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Feb 4, 2026 | Fulcrum Therapeutics, Inc. (FULC) | Grant/Award | 170,000 | n/a |
| Jul 23, 2025 | Rein Therapeutics, Inc. (RNTX) | Grant/Award | 17,500 | n/a |
| Jan 28, 2025 | Fulcrum Therapeutics, Inc. (FULC) | Grant/Award | 285,000 | n/a |
| Dec 6, 2024 | Aileron Therapeutics, Inc. (ALRN) | Grant/Award | 35,000 | n/a |
| Aug 22, 2024 | Aileron Therapeutics, Inc. (ALRN) | Grant/Award | 2,725 | n/a |
| Jan 31, 2024 | Fulcrum Therapeutics, Inc. (FULC) | Grant/Award | 100,000 | n/a |
| Jan 19, 2024 | Fulcrum Therapeutics, Inc. (FULC) | Grant/Award | 61,822 | n/a |
| Nov 3, 2023 | AILERON THERAPEUTICS INC (ALRN) | Grant/Award | 5,450 | n/a |
| Aug 9, 2023 | Fulcrum Therapeutics, Inc. (FULC) | Grant/Award | 432,800 | n/a |